Fate Therapeutics, Inc. vs Pfizer, Inc. — Stock Comparison

FATE
Fate Therapeutics, Inc.
$1.53
▲ 22.40%
vs
PFE
Pfizer, Inc.
$26.33
▼ 1.39%
Q·Score Winner
Pfizer, Inc.
PFE6.5/10vs 5.4/10

Q·Score Breakdown

5.4
Bearish
Overall
6.5
Neutral
1.6
Quality
7.4
9.7
Health
7
4.7
Growth
5.6
6.5
Valuation
6.7
5.2
Sentiment
5.2
FATE

Clean balance sheet with low leverage (0.4× debt-to-equity).

low return on equity (-52%).

PFE

Strong profitability with 12% net profit margins.

analyst sentiment is cautious.

Analyst Consensus

HOLD
Target $5.19 (+239.1%)
8 analysts
HOLD
Target $29.00 (+10.2%)
27 analysts

Fundamentals

FATE
PFE
Trailing P/E
19.4×
-1.5×
Forward P/E
9.4×
0.0%
Profit Margin
12.4%
0.0%
Gross Margin
75.8%
-51.8%
ROE
8.9%
-26.4%
Revenue Growth
-1.2%
Earnings Growth
2.24
Beta
0.39
Price / Book
$178M
Market Cap
$149.8B
$1 – $2
52-Week Range
$22 – $29

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →